Literature DB >> 1356957

Identification of the HLA-DRB1*04, -DRB1*07, and -DRB1*09 alleles by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours.

H Zetterquist1, O Olerup.   

Abstract

The clinical applicability of genomic HLA class II typing techniques has increased after the introduction of PCR-based typing strategies. In typing by PCR amplification using sequence-specific primers (PCR-SSP), amplification of specific alleles or groups of alleles is achieved, provided that the mismatch(es) of the SSP is located in the 3' end of the primer. Thus, the specificity of the typing system becomes part of the amplification step, which reduces the total typing time to a minimum by simplifying the postamplification processing of samples. The set of primers presented here identifies all of the alleles of the DR4 group, DRB1*0401-DRB1*0411, as well as the DRB1*07 and DRB1*0901 alleles. In the present study of DR4 alleles, PCR-SSP was compared with hybridization with sequence-specific oligonucleotide probes following group-specific PCR amplification (PCR-SSO). The two typing strategies gave completely concordant results in the 90 DR4-positive and the 32 DR4-negative individuals and cell lines studied. DR7,DQ9/DR9,DQ9 discrimination using PCR-SSP, was compared with MspI DQA RFLP typing, also with concordant results in the 33 DR7- and/or DR9-positive and 36 DR7- and DR9-negative individuals and cell lines tested. No false-negative or false-positive typing results were obtained. Genomic typing by PCR-SSP was performed in the overall time of 2 hours, including rapid DNA preparation, PCR amplification, postamplification processing, documentation, and interpretation of results. This makes the PCR-SSP strategy for HLA class II typing attractive not only in population- and disease-association studies, but also in routine clinical practice, including donor-recipient matching prior to cadaveric transplantation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356957     DOI: 10.1016/0198-8859(92)90086-3

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  29 in total

1.  CD4+ T-cell immunity to the Burkholderia pseudomallei ABC transporter LolC in melioidosis.

Authors:  Karen K Chu; Patcharaporn Tippayawat; Nicola J Walker; Sarah V Harding; Helen S Atkins; Bernard Maillere; Gregory J Bancroft; Ganjana Lertmemongkolchai; Daniel M Altmann
Journal:  Eur J Immunol       Date:  2010-12-03       Impact factor: 5.532

2.  Reduced telomere length in rheumatoid arthritis is independent of disease activity and duration.

Authors:  Sophia E Steer; Frances M K Williams; Bernet Kato; Jeffry P Gardner; Paul J Norman; Margaret A Hall; Masayuki Kimura; Robert Vaughan; Abraham Aviv; Tim D Spector
Journal:  Ann Rheum Dis       Date:  2006-11-17       Impact factor: 19.103

3.  Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication.

Authors:  Nilufer Seth; Daniel Kaufmann; Timothy Lahey; Eric S Rosenberg; Kai W Wucherpfennig
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

4.  Association of pelvic endometriosis with alopecia universalis, autoimmune thyroiditis and multiple sclerosis.

Authors:  C Alviggi; P B Carrieri; R Pivonello; V Scarano; M Pezzella; G De Placido; A Colao; G Matarese
Journal:  J Endocrinol Invest       Date:  2006-02       Impact factor: 4.256

5.  Antigen-specific immune responses to influenza vaccine in utero.

Authors:  Deepa Rastogi; Chaodong Wang; Xia Mao; Cynthia Lendor; Paul B Rothman; Rachel L Miller
Journal:  J Clin Invest       Date:  2007-06       Impact factor: 14.808

6.  Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein Gp110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis.

Authors:  E Toussirot; D Wendling; P Tiberghien; J Luka; J Roudier
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

7.  MHC class II, tumour necrosis factor alpha, and lymphotoxin alpha gene haplotype associations with serological subsets of systemic lupus erythematosus.

Authors:  N J McHugh; P Owen; B Cox; J Dunphy; K Welsh
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

8.  No significant association between HLA antigens and classic Kaposi sarcoma: molecular analysis of 49 Jewish patients.

Authors:  L Strichman-Almashanu; S Weltfriend; O Gideoni; R Friedman-Birnbaum; S Pollack
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

9.  Epstein-Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment.

Authors:  Mattias Magnusson; Mikael Brisslert; Kiandoht Zendjanchi; Magnus Lindh; Maria I Bokarewa
Journal:  Rheumatology (Oxford)       Date:  2010-06-14       Impact factor: 7.580

10.  Distributions of HLA-A and -B alleles and haplotypes in the Yi ethnic minority of Yunnan, China: relationship to other populations.

Authors:  Bo-feng Zhu; Guang Yang; Chun-mei Shen; Hai-xia Qin; Shun-zhi Liu; Ya-jun Deng; Shuan-liang Fan; Li-bin Deng; Feng Chen; Ping Zhang; Jie Fang; Li-ping Chen; Hong-dan Wang; Zhen-yuan Wang; Rudolf Lucas
Journal:  J Zhejiang Univ Sci B       Date:  2010-02       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.